News

Search EMA's news announcements

Resultados (3794)

EMA Management Board – highlights of March 2021 meeting

12 Marzo 2021

News Corporate

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 March 2021

12 Marzo 2021

News Human COVID-19 Pharmacovigilance Referrals

Benefits of ifosfamide solutions continue to outweigh risks EMA’s safety committee (PRAC) has concluded that the benefits of ifosfamide solutions for infusion

12 Marzo 2021

News Human Pharmacovigilance Referrals

COVID-19 Vaccine AstraZeneca: PRAC investigating cases of thromboembolic events - vaccine’s benefits currently still outweigh risks - Update

11 Marzo 2021

News Human COVID-19 Vaccines

EMA recommends COVID-19 Vaccine Janssen for authorisation in the EU

11 Marzo 2021

News Human COVID-19 Vaccines

EMA website briefly unavailable on 15 March 2021

11 Marzo 2021

News Corporate

EMA starts rolling review of Eli Lilly antibodies bamlanivimab and etesevimab for COVID-19

11 Marzo 2021

News Human COVID-19 Medicines

COVID-19 Vaccine AstraZeneca: PRAC preliminary view suggests no specific issue with batch used in Austria

10 Marzo 2021

News Human COVID-19 Vaccines

EMA issues advice on use of antibody combination (bamlanivimab / etesevimab)

5 Marzo 2021

News Human COVID-19 Medicines

EMA website briefly unavailable on 8 March 2021

5 Marzo 2021

News Corporate